How to transfer my Strattera prescription to Florida

If you’re exploring treatment options for ADHD, you’ve likely wondered whether telehealth can provide the care you need—especially when it comes to medication. The short answer is yes, and non-stimulant ADHD medications like Strattera (atomoxetine) are actually easier to access through telehealth than their stimulant counterparts.

Unlike controlled stimulant medications such as Adderall or Ritalin, non-stimulant ADHD medications aren’t subject to the same federal restrictions that have complicated telehealth prescribing during recent years. This makes them an accessible, effective option for many people seeking convenient, quality care from home.

In this comprehensive guide, we’ll walk you through everything you need to know about getting non-stimulant ADHD medication via telehealth—from federal regulations and state-specific rules to what you can expect during your virtual appointment.

Understanding Non-Stimulant ADHD Medications

What Makes Non-Stimulants Different?

Non-stimulant medications for ADHD work differently than stimulants both in how they affect your brain and how they’re regulated. Strattera (atomoxetine) is the most commonly prescribed non-stimulant ADHD medication and is not classified as a controlled substance by the DEA. This distinction is crucial for telehealth access.

Unlike stimulants that increase dopamine levels quickly, Strattera is a selective norepinephrine reuptake inhibitor (SNRI) that works gradually over several weeks. While this means it doesn’t provide the immediate symptom relief that stimulants do, it offers several advantages:

• No abuse potential or risk of dependency
• More flexible prescribing (longer supplies, easier refills)
• Steady symptom control throughout the day
• May be better tolerated by people with anxiety or substance use history
• Fewer restrictions on telehealth prescribing

Who Should Consider Non-Stimulants?

Non-stimulant medications can be an excellent choice if you:

• Have a history of substance abuse or are in recovery
• Experience significant anxiety alongside ADHD
• Have cardiovascular concerns that make stimulants risky
• Haven’t responded well to stimulants or experienced intolerable side effects
• Prefer to avoid controlled substances
• Need more consistent, around-the-clock symptom management

Your telehealth provider will help determine whether a non-stimulant medication is the right fit for your specific situation, medical history, and treatment goals.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Regulations: What You Need to Know

The Current Landscape (As of December 2025)

The regulatory environment for telehealth prescribing has evolved significantly since the COVID-19 pandemic. Here’s what’s currently in place:

For Non-Stimulant ADHD Medications:The Ryan Haight Act of 2008, which typically requires an in-person medical evaluation before prescribing controlled substances online, does not apply to non-controlled medications like Strattera. This means there has never been a federal restriction on prescribing non-stimulant ADHD medications via telehealth—even before the pandemic.

For Stimulant ADHD Medications:The DEA’s ‘Third Temporary Extension’ of COVID-era telehealth flexibilities allows providers to prescribe Schedule II-V controlled substances (including stimulants) via telehealth without a prior in-person exam. This extension runs through December 31, 2025, with a fourth extension anticipated for 2026 currently under review.

What This Means for Patients

If you’re seeking non-stimulant medication like Strattera, federal law poses no special barriers to telehealth prescribing. A licensed healthcare provider can:

• Conduct a comprehensive evaluation via video
• Establish a diagnosis
• Prescribe medication
• Send the prescription electronically to your pharmacy

All of this can happen during your first telehealth appointment, provided the provider determines treatment is appropriate and safe for you.

State-by-State Telehealth Rules for ADHD Treatment

While federal law doesn’t restrict non-stimulant prescribing via telehealth, state regulations vary. Here’s what you need to know about key states:

California: Telehealth-Friendly with Modern Standards

California allows telehealth for ADHD treatment without requiring an in-person exam for non-controlled medications. The state has embraced telehealth broadly, and nurse practitioners can practice independently after meeting experience requirements under AB 890.

Key Points:

• No in-person visit required for Strattera or other non-controlled ADHD medications
• Telehealth exam satisfies the ‘good faith exam’ standard
• E-prescribing is standard practice
• Pending legislation (AB 1503) aims to further clarify telehealth prescribing definitions

New York: Stricter for Controlled Substances

New York implemented more restrictive rules in May 2025, requiring an initial in-person evaluation before prescribing any controlled substance via telehealth. However, this rule does not affect non-controlled medications.

Key Points:

• Strattera and other non-controlled ADHD medications can be prescribed via telehealth without an in-person visit
• Nurse practitioners have full independent practice authority
• Stimulant medications require an initial in-person exam under the 2025 rule
• PDMP checks required for all controlled substance prescriptions

Florida: Psychiatric Exception Makes ADHD Care Accessible

Florida has specific rules about Schedule II prescribing via telehealth, but ADHD treatment falls under a psychiatric care exception that makes it more accessible than general controlled substance prescribing.

Key Points:

• Telehealth is fully allowed for ADHD (including medications)
• No in-person visit required for non-controlled medications
• Schedule II stimulants can be prescribed via telehealth for psychiatric conditions (ADHD qualifies)
• PDMP must be checked before every controlled substance prescription
• Nurse practitioners and physician assistants work under collaborative agreements

Texas: Mental Health Telehealth Strongly Supported

Texas has embraced telehealth for mental health and chronic care, though nurse practitioner authority for Schedule II medications remains limited to specific settings.

Key Points:

• Telehealth is widely permitted for ADHD treatment
• No in-person requirement for non-controlled medications
• Physicians can prescribe all ADHD medications via telehealth
• Nurse practitioners can prescribe Schedule II only in hospital or hospice settings
• PDMP checks recommended but not legally mandated for stimulants (required for opioids/benzodiazepines)

Alabama: Strictest Requirements

Alabama maintains some of the most restrictive telehealth rules in the nation, though there’s an important exception for mental health services.

Key Points:

• Requires in-person visit within 12 months for ongoing telehealth treatment of most conditions
• Mental health services are exempt from the annual in-person requirement
• ADHD treatment may fall under the mental health exemption
• Nurse practitioners can prescribe controlled substances with special credentials (QACSC permit)
• A healthcare professional may need to be present with the patient during initial telehealth visits for controlled medications

New Hampshire: Recently Expanded Access

New Hampshire significantly liberalized its telehealth rules in August 2025, removing previous in-person requirements.

Key Points:

• No initial in-person exam required (as of August 2025)
• Annual follow-up evaluation required for ongoing controlled substance prescriptions (can be via telehealth)
• Nurse practitioners have full independent practice authority
• PDMP check required before each controlled substance prescription
• Among the most telehealth-friendly states as of late 2025

Georgia: Standard Telehealth Allowed

Georgia permits telehealth for ADHD without special state-imposed in-person requirements, though nurse practitioner authority for controlled substances is limited.

Key Points:

• Telehealth allowed for ADHD treatment
• No in-person visit mandated for non-controlled medications
• PDMP check required at first controlled prescription, then every 90 days
• Nurse practitioners cannot prescribe Schedule II medications (including stimulants) even with physician supervision
• Non-controlled medications like Strattera can be prescribed by NPs under collaborative agreements

What to Expect During Your Telehealth ADHD Evaluation

Comprehensive Assessment, Not a Quick Fix

If you’re considering telehealth for ADHD treatment, it’s important to understand that legitimate providers conduct thorough evaluations—not rubber-stamp prescriptions. Here’s what a proper assessment involves:

Initial Intake:

• Detailed symptom questionnaire
• Medical history review
• Mental health screening
• Substance use history
• Current medications and supplements
• Family history of ADHD and other conditions

Video Consultation:Your provider will spend 30-60 minutes discussing:

• When symptoms started and how they’ve affected different areas of your life
• Specific examples of inattention, hyperactivity, or impulsivity
• Impact on work, school, relationships, and daily functioning
• Previous treatments and their outcomes
• Your goals for treatment
• Potential contraindications or risk factors

Diagnostic Criteria:Providers use DSM-5 criteria, which require:

• Six or more symptoms of inattention and/or hyperactivity-impulsivity
• Symptoms present for at least 6 months
• Evidence of impairment in multiple settings (not just work or just home)
• Symptoms that aren’t better explained by another condition
• For adults, evidence that symptoms were present before age 12

Supporting Documentation:You may be asked to provide:

• Past medical or psychiatric records
• School report cards or performance reviews showing consistent patterns
• Input from a family member or partner who can speak to your symptoms
• Completed rating scales (like ASRS or Conners scales)

When Treatment Begins

If your provider determines that ADHD medication is appropriate, they’ll discuss:

Medication Options:

• Why they’re recommending a non-stimulant versus stimulant (or vice versa)
• Expected timeline for symptom improvement
• Potential side effects and how to manage them
• What to do if the medication doesn’t work or causes problems

For Strattera Specifically:

• Takes 4-6 weeks to reach full effectiveness (unlike stimulants that work immediately)
• May cause temporary nausea, decreased appetite, or sleepiness when starting
• Needs to be taken consistently (not on an as-needed basis)
• Can be prescribed in 90-day supplies for convenience
• Requires monitoring for mood changes, especially in adolescents and young adults

Treatment Plan:Your provider will establish:

• Starting dose and titration schedule
• Follow-up appointment timeline (typically 2-4 weeks initially)
• How to reach them if you have concerns
• Coordination with other providers (primary care doctor, therapist)
• Recommendations for non-medication strategies (therapy, coaching, lifestyle changes)

Klarity Health: Simplifying ADHD Care Through Telehealth

Finding the right ADHD treatment shouldn’t be complicated or time-consuming. At Klarity Health, we’ve built a telehealth platform specifically designed to make mental health care—including ADHD treatment—accessible, affordable, and personalized.

Why Patients Choose Klarity for ADHD Care

Licensed Providers in Your State:Our network includes board-certified physicians and nurse practitioners licensed in all 50 states, ensuring you’re getting care that complies with your state’s specific regulations. When you book an appointment with Klarity, you’re matched with a provider who can legally prescribe in your location.

Transparent, Affordable Pricing:We believe you should know exactly what your care will cost before your appointment. Klarity offers:

• Insurance accepted for those with coverage
• Cash-pay options with clear, upfront pricing for those without insurance or who prefer self-pay
• No surprise bills or hidden fees
• Same pricing whether you’re seeking stimulant or non-stimulant medication

Fast Availability:Unlike traditional psychiatry appointments that can take months to secure, Klarity offers:

• Appointments often available within 24-48 hours
• Flexible scheduling, including evenings and weekends
• Video visits from the comfort of your home
• No commute, no waiting rooms, no lost work time

Comprehensive ADHD Treatment:Our providers don’t just write prescriptions—they partner with you on a complete treatment approach:

• Thorough diagnostic evaluation
• Personalized medication management
• Regular follow-ups to adjust treatment as needed
• Coordination with therapists and other providers
• Evidence-based recommendations for lifestyle strategies

Ongoing Support:ADHD treatment isn’t a one-time prescription—it’s an ongoing relationship. Klarity makes it easy to:

• Schedule regular follow-ups
• Communicate with your provider between visits
• Get prescription refills sent directly to your pharmacy
• Adjust your treatment plan as your needs change

Getting Started Is Simple

1. Create your account at Klarity Health
2. Complete a brief assessment about your symptoms and history
3. Choose an appointment time that works for your schedule
4. Meet with your provider via secure video
5. Receive your treatment plan and prescription (if appropriate) the same day

Whether you’re newly seeking an ADHD diagnosis or looking to transfer your care to a more convenient platform, Klarity’s providers are ready to help you find the right treatment approach.

Insurance, Cost, and Pharmacy Considerations

Insurance Coverage for Telehealth ADHD Treatment

Most insurance plans now cover telehealth mental health visits at the same rate as in-person appointments, thanks to parity laws strengthened during the pandemic. This includes:

• Medicare: Covers telehealth for behavioral health services
• Medicaid: Coverage varies by state but generally includes telehealth mental health care
• Private insurance: Most plans cover telehealth psychiatry and medication management

What to Verify with Your Insurance:

• Whether your plan covers telehealth mental health services
• If prior authorization is needed for ADHD medications
• Your copay or coinsurance for psychiatric visits
• Whether your pharmacy is in-network
• Any step therapy requirements (trying one medication before another is covered)

Medication Costs

For Strattera and Other Non-Stimulants:

• Generic atomoxetine is significantly cheaper than brand-name Strattera
• Typical costs: $30-$100/month for generic with insurance; $300-400+ for brand without insurance
• Most insurance plans cover generic atomoxetine with minimal copay
• Manufacturer coupons may be available for brand-name prescriptions

Cost-Saving Tips:

• Ask about 90-day supplies (often cheaper per month)
• Compare prices at different pharmacies (costs can vary significantly)
• Check GoodRx or similar discount programs if paying out-of-pocket
• Ask your provider about generic options
• Inquire about manufacturer patient assistance programs if cost is a barrier

Filling Your Prescription

When your provider sends your prescription electronically:

For Non-Controlled Medications (like Strattera):

• Can be sent to any pharmacy you choose
• Refills can be included (typically up to 11 refills within one year)
• Can be transferred between pharmacies if needed
• Mail-order pharmacy is an option for 90-day supplies

Potential Pharmacy Questions:Some pharmacies have increased scrutiny of telehealth prescriptions for ADHD medications due to recent regulatory concerns. This typically affects stimulants more than non-stimulants, but you may occasionally encounter:

• Questions about your provider (name, DEA number)
• Request for provider contact information
• Verification that this is a legitimate prescription

Using a reputable telehealth service like Klarity helps avoid these issues, as pharmacists recognize established providers and e-prescription systems.

Safety, Monitoring, and Follow-Up Care

Ensuring Safe Treatment Through Telehealth

While telehealth offers convenience, your safety remains the top priority. Here’s how responsible providers ensure quality care:

Initial Screening for Contraindications:Your provider will screen for conditions that might make Strattera unsafe, including:

• Narrow-angle glaucoma
• Severe cardiovascular disease
• Uncontrolled high blood pressure
• Liver problems
• Recent MAOI antidepressant use (within 14 days)
• History of severe allergic reactions to atomoxetine

Baseline Health Information:Before starting medication, your provider should know:

• Your blood pressure and heart rate (you may be asked to check these at home)
• Any history of heart problems in your family
• Current mental health status, especially any suicidal thoughts
• Liver function (if you have a history of liver disease)
• Any medications or supplements that could interact

Informed Consent:Your provider should clearly explain:

• How the medication works and expected timeline
• Common and serious side effects to watch for
• FDA warnings (including suicidal ideation risk in youth, cardiovascular effects)
• When to seek emergency care
• That treatment requires ongoing monitoring

Ongoing Monitoring and Follow-Up

Initial Follow-Up (2-4 Weeks):Your first follow-up appointment will assess:

• How you’re tolerating the medication
• Any side effects
• Early response to treatment
• Whether dose adjustment is needed
• Questions or concerns that have arisen

Regular Monitoring:During ongoing treatment, your provider will track:

• Blood pressure and heart rate – Strattera can cause increases; this should be checked regularly
• Growth in children and adolescents – Non-stimulants can sometimes affect appetite and growth
• Mood and mental status – Particularly in the first few months, as there’s a small increased risk of suicidal thoughts
• Symptom improvement – Using rating scales or functional assessments
• Side effect management – Adjusting timing or dose to minimize issues
• Liver function – If you develop symptoms like jaundice, dark urine, or severe stomach pain

Frequency of Visits:

• Monthly initially while titrating to the right dose
• Every 3-6 months once stable
• More frequently if concerns arise or treatment changes

What If Strattera Doesn’t Work?

Non-stimulants work well for many people, but they’re not effective for everyone. If after 6-8 weeks at a therapeutic dose you’re not seeing adequate improvement, your provider may:

• Increase the dose (within safe limits)
• Switch to a different non-stimulant (like guanfacine or clonidine)
• Consider adding or switching to a stimulant medication
• Recommend combination therapy
• Refer to a specialist for more complex cases

The flexibility of telehealth means you can easily check in with your provider to make adjustments without the hassle of scheduling in-person appointments weeks out.

Addressing Common Concerns and Misconceptions

‘Aren’t online ADHD prescriptions sketchy?’

This concern isn’t entirely without merit—the telehealth ADHD space has faced scrutiny after some companies were investigated for questionable prescribing practices. However, legitimate telehealth services are held to the same standards as in-person care.

Red flags to avoid:

• Guarantees of prescription before evaluation
• No video consultation (text or phone-only)
• Minimal questioning about symptoms or history
• Pressure to choose specific medications
• No follow-up care or monitoring
• Unusually low prices that seem too good to be true

Signs of quality telehealth care:

• Licensed providers clearly identified
• Comprehensive intake and assessment
• Video consultation required
• Discussion of risks, benefits, and alternatives
• Clear treatment plan with follow-up
• Coordination with other providers
• Transparent about what they can and cannot treat via telehealth

Platforms like Klarity Health have responded to industry concerns by implementing rigorous clinical protocols, requiring thorough evaluations, and emphasizing patient safety at every step.

‘I heard telehealth ADHD prescribing is going away’

For non-stimulant medications, this isn’t a concern. Federal law has never restricted telehealth prescribing of non-controlled substances like Strattera.

For stimulant medications, the current federal allowance does have an expiration date (December 31, 2025), but:

• A fourth extension for 2026 is anticipated and already under review
• Congress is considering permanent telehealth prescribing pathways
• Even if temporary rules expire, the DEA has proposed a ‘Special Registration’ system that could create permanent telehealth options
• Your provider will keep you informed of any changes well in advance

The trend in healthcare is toward expanding, not restricting, telehealth access—particularly for mental health care where there are significant provider shortages.

‘Will my pharmacy refuse to fill a telehealth prescription?’

This is rare, especially for non-controlled medications. Pharmacists are familiar with e-prescriptions from telehealth providers and fill them routinely.

That said, some pharmacies did increase scrutiny following the 2023 controversies around ADHD telehealth startups. To avoid issues:

• Use a reputable telehealth platform with established provider networks
• Have your provider’s contact information readily available
• Choose a pharmacy you’ll use consistently (builds relationship and history)
• Be prepared to show ID and insurance information as you would for any prescription
• If a pharmacy seems hesitant, calmly provide information about your provider

For Strattera specifically, pharmacy concerns are minimal since it’s not a controlled substance and carries no abuse potential.

‘Non-stimulants don’t work as well as stimulants’

This is a common misconception. While stimulants are considered first-line treatment for ADHD due to higher response rates and faster onset, non-stimulants can be equally or more effective for certain individuals.

Research shows:

• About 40-50% of patients respond well to Strattera
• Improvement in ADHD symptoms is comparable to stimulants for responders, though it takes longer to see results
• Benefits include consistent 24-hour coverage without the ‘wear-off’ effect of short-acting stimulants
• May be particularly effective for ADHD with comorbid anxiety
• Some patients who don’t respond to stimulants respond better to non-stimulants

The key is finding the right medication for your brain chemistry and life circumstances—and telehealth providers can help you navigate that decision.

Practical Tips for Successful Telehealth ADHD Treatment

Before Your Appointment

Prepare Your Information:

• List current and past medications
• Document your symptoms with specific examples
• Note when symptoms started and how they’ve impacted your life
• Gather any relevant medical records or school reports
• Write down questions you want to ask

Technical Preparation:

• Test your internet connection and video platform
• Find a private, quiet space for your appointment
• Have your insurance card and ID ready
• Ensure your phone or computer is charged
• Close other applications that might interfere with video quality

Set Realistic Expectations:

• This will be a comprehensive evaluation, not a quick prescription
• Be prepared for a 30-60 minute conversation
• You may not receive medication on the first visit if more evaluation is needed
• Honest, thorough answers help your provider make the best recommendations

During Treatment

Stay Connected with Your Provider:

• Attend all scheduled follow-ups
• Report side effects promptly—don’t wait until the next appointment
• Ask questions when something isn’t clear
• Be honest about how well the medication is working
• Mention any life changes that might affect your treatment

Track Your Progress:

• Keep notes about symptom improvement
• Monitor side effects and when they occur
• Record your blood pressure if asked to do so at home
• Notice patterns in how the medication affects you at different times

Complement Medication with Other Strategies:

• Consider therapy or ADHD coaching
• Implement organizational systems and routines
• Practice good sleep hygiene
• Exercise regularly (especially helpful for ADHD)
• Minimize distractions in your environment
• Communicate your needs to employers, family, or school

Medication Management:

• Take Strattera consistently—it doesn’t work on an as-needed basis
• Don’t skip doses to ‘see if you still need it’
• Set reminders if you’re forgetful (hello, ADHD!)
• Plan ahead for refills so you don’t run out
• Don’t share your medication with others

If You’re Moving or Traveling

Crossing State Lines:

• Telehealth providers must be licensed in the state where you’re located during the appointment
• If you move to a new state, you may need to transfer to a provider licensed there
• For short trips, you can usually continue with your regular provider
• Some platforms like Klarity have providers licensed in multiple states, making transitions easier

Prescription Transfers:

• Non-controlled medications like Strattera can be transferred between pharmacies
• If traveling, you can request your prescription be sent to a pharmacy in your destination
• Bring enough medication to cover any travel period
• Carry prescription information when traveling

The Future of Telehealth ADHD Treatment

Anticipated Regulatory Changes

The regulatory landscape continues to evolve:

Federal Level:

• The DEA is expected to announce a fourth extension of telehealth flexibilities for controlled substances into 2026
• A proposed ‘Special Registration’ system could create permanent telehealth prescribing pathways with appropriate safeguards
• Congressional bills like the TREATS Act aim to expand telepsychiatry access
• Permanent frameworks are likely to balance access with safety measures

State Level:

• More states are moving toward permanently liberalized telehealth rules
• Prescription monitoring program (PDMP) integration continues to strengthen
• E-prescribing requirements are becoming universal
• Several states are considering expanding nurse practitioner practice authority

Industry Trends:

• Greater emphasis on comprehensive care (not just prescriptions)
• Integration of therapy and medication management
• Improved coordination with primary care providers
• Enhanced patient screening and safety protocols
• More robust technology platforms for monitoring and communication

What This Means for Patients

The direction is clear: telehealth for mental health care, including ADHD, is here to stay. Whether you need non-stimulant or stimulant medication, access through telehealth is likely to become more standardized and permanent rather than restricted.

For patients seeking non-stimulant ADHD medications specifically, the outlook is entirely positive—there are no anticipated restrictions, only continued improvements in:

• Provider availability
• Insurance coverage
• Technology and platform quality
• Integration with other aspects of healthcare
• Patient education and support

Take the Next Step Toward Better ADHD Management

Living with untreated or poorly managed ADHD doesn’t have to be your reality. Whether you’re newly exploring an ADHD diagnosis or frustrated with your current treatment approach, telehealth offers a convenient, effective pathway to care.

Non-stimulant medications like Strattera can be prescribed safely and legally via telehealth in all 50 states, with no federal or state-imposed in-person visit requirements. This means you can:

• Get evaluated by a licensed provider from home
• Start treatment without months-long waits for appointments
• Receive ongoing care that fits your schedule
• Access affordable options whether you have insurance or prefer cash pay
• Work with providers who understand ADHD and are committed to finding the right treatment for you

Ready to get started? Klarity Health makes it simple to connect with board-certified providers who can evaluate your symptoms, discuss your options, and develop a personalized treatment plan—often with appointments available within 24-48 hours.

You deserve care that works with your life, not against it. Take the first step today.

Citations

1. FierceHealthcare. (November 2024). ‘DEA finalizes one-year extension for controlled substance prescribing via telehealth, punts final rules to 2025.’ Available at: https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final

2. McDermott Will & Emery. (December 2025). ‘DEA Signals Extension of Telemedicine Flexibilities for Controlled Substance Prescribing for 2026.’ Available at: https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/

3. Sheppard Mullin Healthcare Law Blog (National Law Review). (August 15, 2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

4. Medical News Today. (January 14, 2025). ‘Is Strattera a controlled substance?’ Available at: https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance

5. RxAgent. (October 2025). ‘The Telehealth Compliance Trap: Alabama’s Hidden Loophole & NY’s New Rule.’ Available at: https://www.rxagent.co/blog/telehealth-compliance-trap

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment